Janney Capital reiterated a Buy rating and $35.00 price target on DepoMed Inc (NASDAQ: DEPO) following the company's 3Q earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

After-Hours Stock Movers 11/09: (BLCM) (MDR) (RAX) Higher; (LF) (SGMS) (LGF) (GPS) Lower (more...)November 9, 2015 6:09 PM Depomed (DEPO) Tops Q3 EPS by 14cNovember 9, 2015 4:04 PM Depomed Reports Record Sales in Third Quarter 2015 and Raises Full Year 2015 GuidanceNovember 9, 2015 4:01 PM